Abstract:Site-directed spin labeling has qualitatively shown that a key event during activation of rhodopsin is a rigid-body movement of transmembrane helix 6 (TM6) at the cytoplasmic surface of the molecule. To place this result on a quantitative footing, and to identify movements of other helices upon photoactivation, double electron-electron resonance (DEER) spectroscopy was used to determine distances and distance changes between pairs of nitroxide side chains introduced in helices at the cytoplasmic surface of rho… Show more
“…To distinguish between the different submodels will require other, more structure sensitive time-resolved spectral techniques. The scheme presented here, however, is consistent with EPR studies describing the helix-6 movement involved in activation, 31 and G-protein peptide mimic binding studies. 41 Many structural studies reveal complex helix movements involving the rearrangements of H-bonding in the transmembrane region of the protein, and several states of the chromophore relaxation during activation.…”
Section: ■ Conclusionsupporting
confidence: 85%
“…As expected, the ratio of the Meta Ib 480 formation of Meta Ib 480 and the enhanced deprotonation leading to the formation of Meta IIb to the helix-6 movement observed by EPR on a similar time scale. 28,31 This helix movement is necessary for G-protein binding. It is also suggested that the proton uptake by the protein, leading to its active state and causing the anomalous pH dependence of the equilibrium between Meta I and Meta II in Scheme 1, is initiated by the helix movement.…”
ABSTRACT:The late intermediates involved in the activation mechanism of bovine rhodopsin are investigated by time-resolved optical absorption spectroscopy. Measurements from 10 μs to 200 ms after photolysis were carried out on membrane suspensions of bovine rhodopsin at a temperature of 15°C and at pH of 7.3, 8.0, and 8.7. The time-resolved absorption spectra in the 330−650 nm range were analyzed by global exponential and kinetic scheme fitting methods. The results indicate an activation mechanism that is more complex than suggested previously. It involves interconnected branched pathways with two metarhodopsin I 480 and two metarhodopsin II intermediates. The intermediates involved in this more complex mechanism need to be considered in spectroscopic studies that vary sample temperature and pH in order to enhance the presence of specific rhodopsin intermediates.
“…To distinguish between the different submodels will require other, more structure sensitive time-resolved spectral techniques. The scheme presented here, however, is consistent with EPR studies describing the helix-6 movement involved in activation, 31 and G-protein peptide mimic binding studies. 41 Many structural studies reveal complex helix movements involving the rearrangements of H-bonding in the transmembrane region of the protein, and several states of the chromophore relaxation during activation.…”
Section: ■ Conclusionsupporting
confidence: 85%
“…As expected, the ratio of the Meta Ib 480 formation of Meta Ib 480 and the enhanced deprotonation leading to the formation of Meta IIb to the helix-6 movement observed by EPR on a similar time scale. 28,31 This helix movement is necessary for G-protein binding. It is also suggested that the proton uptake by the protein, leading to its active state and causing the anomalous pH dependence of the equilibrium between Meta I and Meta II in Scheme 1, is initiated by the helix movement.…”
ABSTRACT:The late intermediates involved in the activation mechanism of bovine rhodopsin are investigated by time-resolved optical absorption spectroscopy. Measurements from 10 μs to 200 ms after photolysis were carried out on membrane suspensions of bovine rhodopsin at a temperature of 15°C and at pH of 7.3, 8.0, and 8.7. The time-resolved absorption spectra in the 330−650 nm range were analyzed by global exponential and kinetic scheme fitting methods. The results indicate an activation mechanism that is more complex than suggested previously. It involves interconnected branched pathways with two metarhodopsin I 480 and two metarhodopsin II intermediates. The intermediates involved in this more complex mechanism need to be considered in spectroscopic studies that vary sample temperature and pH in order to enhance the presence of specific rhodopsin intermediates.
“…31 In the activation-related scenario, TMH6 undergoes the most important movement where the kink functions as a pivot and finally leads to G-protein coupling and activation. 32,33 Substitution of the proline is expected to lead to modifications in the signaling properties by causing changes in the helix conformation, intramolecular interactions and thereby the helix arrangement. This is supported by recent findings regarding corresponding prolines in other glycoprotein hormone receptors, the thyrotropin receptor (hTSHR, Pro639), 34 and the lutropin/choriogonadotropin receptor (rLHCGR, Pro588).…”
Section: Fsh Resistance Associated With a T(2;8)mentioning
Follicle-stimulating hormone (FSH) mediated by its receptor (FSHR) is pivotal for normal gametogenesis. Inactivating FSHR mutations are known to cause hypergonadotropic hypogonadism with disturbed follicular maturation in females. So far, only very few recessive point mutations have been described. We report on a 17-year-old female with primary amenorrhea, hypergonadotropic hypogonadism and disturbed folliculogenesis. Chromosome analysis detected a seemingly balanced translocation 46,XX,t(2;8)(p16.3or21;p23.1)mat. FSHR sequence analysis revealed a novel non-synonymous point mutation in exon 10 (c.1760C4A, p.Pro587His), but no wild-type allele. The mutation was also found in the father, but not in the mother. Furthermore, molecular-cytogenetic analyses of the breakpoint region on chromosome 2 showed the translocation to be unbalanced, containing a deletion with one breakpoint within the FSHR gene. The deletion size was narrowed down by array analysis to approximately 163 kb, involving exons 9 and 10 of the FSHR gene. Functional studies of the mutation revealed the complete lack of signal transduction presumably caused by a changed conformational structure of transmembrane helix 6. To our knowledge, this is the first description of a compound heterozygosity of an inactivating FSHR point mutation unmasked by a partial deletion. This coincidence of two rare changes caused clinical signs consistent with FSH resistance.
“…The helix movement also results in a pH-dependent protonation of glutamate 134. 14,18,19 Previous studies of the human rhodopsin attempted to characterize human rhodopsin intermediates using both temperature trapping and time-resolved spectroscopic measurements to determine the similarities and differences between the activation of human and bovine rhodopsins. 20,21 It was expected that differences in the sequences of human and bovine rhodopsins in the connection from transmembrane 5 and extracellular loop 2 could affect rhodopsin activation and G-protein binding.…”
Section: R Hodopsin Is a G-protein-coupled Receptor (Gpcr) Foundmentioning
Rhodopsin is a G-protein-coupled receptor important for vertebrate vision under dim light conditions. Many studies of the activation mechanism of bovine rhodopsin have been conducted, but there have been relatively few investigations of the human protein. A recent study of the late photointermediates of bovine rhodopsin studies at 15°C and pH 7.3, 8.0, and 8.7 revealed a rather complex activation mechanism involving two metarhodopsin I 480 and metarhodopsin II intermediates. Human rhodopsin was studied under these same conditions using time-resolved optical absorption spectroscopy with measurements from 10 μs to 200 ms after photolysis. The results show that the two proteins follow the same photoactivation mechanism, although their kinetics differ significantly. The comparison of bovine and human rhodopsins shows that the initial Schiff base deprotonation equilibrium is more forward shifted in human rhodopsin, and more of the reaction flows through the metarhodopsin I 380 intermediate in human rhodopsin than in the bovine protein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.